EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Reframing IL-27: a central regulator of CD8+ T cell immunity

Valentina Venzin, Matteo Iannacone

Trends in Immunology · 2026

DOI: 10.1016/j.it.2025.10.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2026. Verfasst von Valentina Venzin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Transplantation, and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Interleukin-27, Interleukins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, European Research Council, GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin-27 (IL-27), a member of the IL-12 cytokine family, was long viewed primarily as a regulator of CD4+ T cell immunity. Subsequent studies revealed that IL-27 also directly modulates CD8+ T cells, displaying both stimulatory and inhibitory potential. Recent work extends this earlier literature, showing that IL-27 in infection and cancer can promote effector differentiation, sustain survival, and reverse dysfunction, often without the systemic toxicity associated with related cytokines. This review outlines the molecular features, signaling mechanisms, and cellular sources of IL-27, integrating emerging evidence from viral, tumor, and autoimmune settings. We propose that IL-27 operates not as an inherently pro- or anti-inflammatory cytokine but as a context-dependent tuner of CD8+ T cell cytotoxic immunity, offering new opportunities for therapeutic exploitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesInterleukin-27InterleukinsHumansAnimalsSignal TransductionNeoplasmsCell Differentiation

Stichwörter der Autor:innen

CD8(+) T cell immunityIL-27T cell dysfunctioncytokine signalingcytotoxic T lymphocytesimmunotherapy

Substanzen

Interleukin-27Interleukins

Autor:innen und Institutionen

  • Division of Immunology, Transplantation, and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan,…

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • European Research Council
  • GlaxoSmithKline
  • Medical Research Council
  • Italian Association for Cancer Research
  • Gilead Sciences
  • BioNTech

Zitieren

APA

Venzin, V., & Iannacone, M. (2026). Reframing IL-27: a central regulator of CD8+ T cell immunity. Trends in Immunology. https://doi.org/10.1016/j.it.2025.10.012

Vancouver

Venzin V, Iannacone M. Reframing IL-27: a central regulator of CD8+ T cell immunity. Trends in Immunology. 2026. doi:10.1016/j.it.2025.10.012

BibTeX
@article{Venzin2026,
  author = {Venzin, Valentina and Iannacone, Matteo},
  title = {Reframing IL-27: a central regulator of CD8+ T cell immunity},
  journal = {Trends in Immunology},
  year = {2026},
  doi = {10.1016/j.it.2025.10.012}
}
Kostenlos starten →